ATE311457T1 - Basb029 polynucleotide und polypeptide aus neisseria meningitis - Google Patents

Basb029 polynucleotide und polypeptide aus neisseria meningitis

Info

Publication number
ATE311457T1
ATE311457T1 AT99924946T AT99924946T ATE311457T1 AT E311457 T1 ATE311457 T1 AT E311457T1 AT 99924946 T AT99924946 T AT 99924946T AT 99924946 T AT99924946 T AT 99924946T AT E311457 T1 ATE311457 T1 AT E311457T1
Authority
AT
Austria
Prior art keywords
polypeptides
basb029
neisseria meningitis
polynucleotides
basb029 polynucleotides
Prior art date
Application number
AT99924946T
Other languages
English (en)
Inventor
Jean-Louis Ruelle
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10831992&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE311457(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Application granted granted Critical
Publication of ATE311457T1 publication Critical patent/ATE311457T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1217—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
AT99924946T 1998-05-13 1999-05-07 Basb029 polynucleotide und polypeptide aus neisseria meningitis ATE311457T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810276.7A GB9810276D0 (en) 1998-05-13 1998-05-13 Novel compounds
PCT/EP1999/003255 WO1999058683A2 (en) 1998-05-13 1999-05-07 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS)

Publications (1)

Publication Number Publication Date
ATE311457T1 true ATE311457T1 (de) 2005-12-15

Family

ID=10831992

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99924946T ATE311457T1 (de) 1998-05-13 1999-05-07 Basb029 polynucleotide und polypeptide aus neisseria meningitis

Country Status (24)

Country Link
US (3) US6780419B1 (de)
EP (2) EP1078063B1 (de)
JP (2) JP4707832B2 (de)
KR (4) KR20080070073A (de)
CN (1) CN1322127C (de)
AT (1) ATE311457T1 (de)
AU (1) AU750032B2 (de)
BR (1) BR9910396A (de)
CA (1) CA2328403C (de)
CY (1) CY1105676T1 (de)
CZ (1) CZ299612B6 (de)
DE (1) DE69928658T2 (de)
DK (1) DK1078063T3 (de)
ES (1) ES2252946T3 (de)
GB (1) GB9810276D0 (de)
HK (1) HK1036300A1 (de)
HU (1) HUP0102479A3 (de)
IL (2) IL139613A0 (de)
NO (2) NO326994B1 (de)
NZ (1) NZ508323A (de)
PL (1) PL197449B1 (de)
TR (1) TR200003347T2 (de)
WO (1) WO1999058683A2 (de)
ZA (1) ZA200006523B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
PT1047784E (pt) * 1998-01-14 2009-12-21 Novartis Vaccines & Diagnostic Antigénios de neisseria meningitidis
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
JP4812942B2 (ja) 1999-02-26 2011-11-09 ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル ＣＧモチーフを含むオリゴヌクレオチドを用いるＮｅｉｓｓｅｒｉａ抗原殺菌活性の増強
GB9916529D0 (en) * 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
CA2864069A1 (en) 1999-10-29 2001-05-03 Novartis Vaccines And Diagnostics S.R.L. Neisserial antigenic peptides
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
CA2871789C (en) 2000-01-17 2017-04-04 Novartis Vaccines And Diagnostics S.R.L. Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
CN1419564A (zh) 2000-01-25 2003-05-21 昆士兰大学 包含脑膜炎奈瑟氏球菌表面抗原NhhA的保守区域的蛋白质
EP2270030B1 (de) 2000-02-28 2012-05-23 Novartis Vaccines and Diagnostics S.r.l. Heterologe Expression Neisserscher Proteine
JP4592284B2 (ja) 2001-07-27 2010-12-01 カイロン ソチエタ ア レスポンサビリタ リミタータ 髄膜炎菌付着因子
TWI360424B (en) * 2002-08-02 2012-03-21 Glaxosmithkline Biolog Sa Vaccine
PT1549338E (pt) 2002-10-11 2011-02-23 Novartis Vaccines & Diagnostic Vacinas polipeptídicas para protecção alargada contra linhagens meningocócicas hipervirulentas
PL1670506T3 (pl) 2003-10-02 2013-04-30 Novartis Ag Płynne szczepionki przeciw wielu grupom serologicznym meningokoków
US7459930B2 (en) * 2006-11-14 2008-12-02 Micron Technology, Inc. Digital calibration circuits, devices and systems including same, and methods of operation
GB0700562D0 (en) 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
GB0916570D0 (en) 2009-09-21 2009-10-28 Royal Holloway & Bedford New C Method
JP2013522177A (ja) 2010-03-11 2013-06-13 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム グラム陰性細菌性、例えば髄膜炎菌性の感染または疾患に対する免疫原性組成物またはワクチン
CA2859078A1 (en) * 2012-01-05 2013-07-11 Deutsches Krebsforschungszentrum Means and methods for treating or diagnosing idh1 r132h mutant-positive cancers
KR102534060B1 (ko) 2016-07-27 2023-05-19 프리즈미안 에스피에이 가요성 광섬유 리본

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769240A (en) * 1980-09-15 1988-09-06 Bactex, Inc. Pili of neisseria and vaccine compositions containing same
US4702911A (en) * 1985-09-27 1987-10-27 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
JPH01125328A (ja) * 1987-07-30 1989-05-17 Centro Natl De Biopreparados 髄膜炎菌ワクチン
FR2682041B1 (fr) * 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins Vaccin contre les infections a neisseria meningitidis.
US6245337B1 (en) * 1994-08-25 2001-06-12 Washington University Haemophilus adherence and penetration proteins
US6121037A (en) * 1994-10-18 2000-09-19 Stojiljkovic; Igor Bacterial hemoglobin receptor genes
US5646259A (en) * 1995-03-24 1997-07-08 St. Louis University DNA encoding haemophilus adhesion proteins
US6265567B1 (en) * 1995-04-07 2001-07-24 University Of North Carolina At Chapel Hill Isolated FrpB nucleic acid molecule
CU22559A1 (es) * 1996-01-17 1999-05-03 Ct Ingenieria Genetica Biotech Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
PT1047784E (pt) * 1998-01-14 2009-12-21 Novartis Vaccines & Diagnostic Antigénios de neisseria meningitidis
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
ES2397918T3 (es) * 1999-04-30 2013-03-12 Novartis Vaccines And Diagnostics S.R.L. Antígenos Neisseriales conservados

Also Published As

Publication number Publication date
JP2010166921A (ja) 2010-08-05
CN1309707A (zh) 2001-08-22
HUP0102479A2 (hu) 2001-10-28
TR200003347T2 (tr) 2001-06-21
WO1999058683A3 (en) 2000-04-06
NO20005696L (no) 2001-01-11
KR20010043571A (ko) 2001-05-25
NO20090955L (no) 2001-01-11
ZA200006523B (en) 2001-11-12
AU4142099A (en) 1999-11-29
KR20080070073A (ko) 2008-07-29
EP1621623A3 (de) 2009-02-18
IL139613A (en) 2014-03-31
HK1036300A1 (en) 2001-12-28
EP1621623A2 (de) 2006-02-01
EP1078063B1 (de) 2005-11-30
JP2002514424A (ja) 2002-05-21
EP1078063A2 (de) 2001-02-28
WO1999058683A2 (en) 1999-11-18
HUP0102479A3 (en) 2004-10-28
CZ299612B6 (cs) 2008-09-17
DK1078063T3 (da) 2006-04-03
KR20060076789A (ko) 2006-07-04
US20090093622A1 (en) 2009-04-09
DE69928658T2 (de) 2006-06-14
KR100897951B1 (ko) 2009-05-18
PL197449B1 (pl) 2008-03-31
NZ508323A (en) 2002-10-25
AU750032B2 (en) 2002-07-11
CY1105676T1 (el) 2010-12-22
GB9810276D0 (en) 1998-07-15
US20040265332A1 (en) 2004-12-30
WO1999058683A9 (en) 2002-05-02
CA2328403A1 (en) 1999-11-18
CN1322127C (zh) 2007-06-20
ES2252946T3 (es) 2006-05-16
KR20100019461A (ko) 2010-02-18
NO20005696D0 (no) 2000-11-10
PL345281A1 (en) 2001-12-03
JP4707832B2 (ja) 2011-06-22
NO326994B1 (no) 2009-03-30
DE69928658D1 (de) 2006-01-05
IL139613A0 (en) 2002-02-10
US6780419B1 (en) 2004-08-24
BR9910396A (pt) 2001-10-30
CA2328403C (en) 2013-11-05
CZ20004202A3 (en) 2001-05-16
KR100673674B1 (ko) 2007-01-23

Similar Documents

Publication Publication Date Title
DE69928658T2 (de) Basb029 polynucleotide und polypeptide aus neisseria meningitis
WO1999055873A3 (en) Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
CY1108280T1 (el) Basb205 πολυπεπτιδια και πολυνουκλεοτιδια που τα κωδικοποιουν
ATE270332T1 (de) Polynucleotide and polypeptide basb033 aus neisseria meningitidis und ihre verwendungen
DE69928925D1 (de) Antigene polypeptide aus neisseria meningitidis, dafür kodierende polynukleotide und entsprechende schützende antikörper
DE60043499D1 (de) Antigene polypeptide aus neisseria meningitidis, dafür kodierende polynukleotide und entsprechende schützende antikörper
ATE312922T1 (de) Moraxella catarrhalis polynukleotide und polypeptide
DE69927017D1 (de) Verbindungen aus moraxella catarrhalis
GB9812163D0 (en) Novel compounds
DE60043658D1 (de) Basb118 polypeptid und polynukleotid aus moraxella catarrhalis
ATE527360T1 (de) Neue verbindungen abgeleitet von neisseria meningitidis
DE60140006D1 (de) Polypeptide aus haemophilus influenza
ATE360073T1 (de) Basb119 polypeptid und polynukleotid aus moraxella catarrhalis
ATE274582T1 (de) Basb028 polypeptiden und dafür kodierende polynukleotiden aus moraxella catarrhalis
ATE515511T1 (de) Nicht-typisierbare haemophilus influenzae basb201 polypeptide und polynukleotide und deren verwendungen
DE60039303D1 (de) Immunogene polypeptide aus moraxella catarrhalis und deren verwendungen
ATE311458T1 (de) Basb111 polypeptid und polynukleotid aus moraxella catharralis
DE60035788D1 (de) Polypeptide aus moraxella (branhamella) catarrhalis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1078063

Country of ref document: EP